TDAC Translational Development Acquisition Corp.

CIK 0001926599 10 ready 8-Ks latest July 27, 2026, 4:05 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 10

Latest filing July 27, 2026, 4:05 PM ET

Top materiality 0.90

Event mix other_material ×5 · m_and_a ×2 · other ×2

Sentiment 1 pos · 1 neg · 8 neu

SHENANIGAN SCORE 1 / 7 see the board

Recent 8-K filings for TDAC

Highest-materiality recent filing

TDAC to merge with battery maker ProLogium at ~$3.8B enterprise value

May 27, 2026, 7:37 AM ET M&A materiality 0.90 neutral item 1.01 item 7.01 item 9.01 ◈ Material Agreements

Deal implies ~$3.8B valuation for ProLogium on a net cash-free basis.
Combined company to be named ProLogium Technology and list on Nasdaq as PRLG.

Read filing →

July 27, 2026, 4:05 PM ET other material materiality 0.70 neutral item 1.01 item 3.02 item 9.01

TDAC secures $50M PIPE commitment from Naetas Holding for ProLogium business combination

Naetas Holding agrees to buy 5M TDAC Class A shares at $10.00 each for $50M total, plus 5M warrants at $11.50 exercise.
July 8, 2026, 8:05 AM ET M&A materiality 0.50 neutral item 8.01 item 9.01

TDAC announces ProLogium files F-4 registration statement for de-SPAC merger

ProLogium filed initial F-4 with SEC for merger with TDAC.
June 23, 2026, 10:18 AM ET other material materiality 0.70 positive item 8.01 item 9.01

TDAC secures 85% shareholder retention, $156.8M trust intact after extension vote

85% of shares not redeemed; 14.65M shares held, only 2.60M redeemed after June 17 vote.
June 18, 2026, 9:23 AM ET other material materiality 0.60 neutral item 1.01 item 5.03 item 5.07 item 9.01 ◈ Shareholder Votes ×3◈ Governance Changes◈ Material Agreements

TDAC shareholders approve extension to June 2027; ~$27.8M redeemed at $10.70/share

Shareholders approved extending business combination deadline from June 24, 2026 to June 24, 2027 via up to 12 monthly extensions.
June 12, 2026, 4:06 PM ET other material materiality 0.20 neutral item 3.02 ◈ Equity Issuances

Translational Development converts 4.66M Class B shares to Class A; no cash proceeds

4,657,499 Class B ordinary shares converted to an equal number of Class A shares by Sponsor TDAC Partners LLC.
May 27, 2026, 7:37 AM ET M&A materiality 0.90 neutral item 1.01 item 7.01 item 9.01 ◈ Material Agreements

TDAC to merge with battery maker ProLogium at ~$3.8B enterprise value

Deal implies ~$3.8B valuation for ProLogium on a net cash-free basis.
August 14, 2025, 7:59 PM ET debt materiality 0.45 neutral item 2.03 item 8.01 item 9.01

Translational Development Acquisition Corp. obtains up to $2M working capital loan from sponsor

Sponsor TDAC Partners LLC provides up to $2,000,000 non-interest bearing loan for working capital.
February 14, 2025, 6:59 PM ET other materiality 0.25 neutral item 8.01 item 9.01

TDAC announces separate trading of Class A shares and warrants effective Feb 14

Separate trading of Class A ordinary shares (TDAC) and warrants (TDACW) commenced Feb 14, 2025.
December 31, 2024, 6:59 PM ET other material materiality 0.85 negative item 8.01 item 9.01

SPAC Translational Development closes $172.5M IPO; auditor flags going concern

IPO of 17,250,000 units at $10.00/unit (including over-allotment), gross proceeds $172.5M.
December 27, 2024, 6:59 PM ET other materiality 0.55 neutral item 1.01 item 3.02 item 5.02 item 5.03 item 8.01 item 9.01 ◈ Governance Changes

SPAC Translational Development closes $172.5M IPO with full over-allotment

IPO of 17.25M units at $10/unit raised $172.5M gross; units list on Nasdaq under TDACU.

Materiality & sentiment trend

Max materiality 0.90 · Median 0.57 · Most common event other_material

1 positive 1 negative 8 neutral

source · TDAC on sec.gov